Allspring Global Investments Holdings, LLC Enanta Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 95 shares of ENTA stock, worth $530. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 2,667 96.44%
Holding current value
$530
Previous $34,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$10.05 - $16.54 $25,848 - $42,540
-2,572 Reduced 96.44%
95 $0
Q2 2024

Jul 26, 2024
BUY
$11.43 - $17.02 $30,483 - $45,392
2,667 New
2,667 $34,000
Q4 2023

Jan 25, 2024
SELL
$8.18 - $10.78 $875 - $1,153
-107 Reduced 17.51%
504 $4,000
Q3 2023

Oct 27, 2023
BUY
$11.09 - $22.13 $6,775 - $13,521
611 New
611 $6,000
Q2 2023

Jul 18, 2023
SELL
$20.68 - $39.85 $7,279 - $14,027
-352 Reduced 13.9%
2,180 $46,000
Q1 2023

Apr 13, 2023
SELL
$38.82 - $54.59 $36,490 - $51,314
-940 Reduced 27.07%
2,532 $102,000
Q4 2022

Jan 23, 2023
SELL
$40.77 - $53.73 $84,190 - $110,952
-2,065 Reduced 37.29%
3,472 $0
Q3 2022

Oct 26, 2022
BUY
$48.29 - $71.27 $123,236 - $181,881
2,552 Added 85.49%
5,537 $287,000
Q2 2022

Jul 25, 2022
SELL
$38.13 - $76.93 $566,077 - $1.14 Million
-14,846 Reduced 83.26%
2,985 $141,000
Q1 2022

May 02, 2022
BUY
$56.06 - $74.11 $164,592 - $217,586
2,936 Added 19.71%
17,831 $1.27 Million
Q4 2021

Jan 28, 2022
BUY
$60.19 - $97.37 $896,530 - $1.45 Million
14,895 New
14,895 $1.11 Million

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $116M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email